Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soybean (Glycine max) allergy in Europe: Gly m 5 (beta-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy.
Holzhauser T, Wackermann O, Ballmer-Weber BK, Bindslev-Jensen C, Scibilia J, Perono-Garoffo L, Utsumi S, Poulsen LK, Vieths S. Holzhauser T, et al. Among authors: vieths s. J Allergy Clin Immunol. 2009 Feb;123(2):452-8. doi: 10.1016/j.jaci.2008.09.034. Epub 2008 Nov 8. J Allergy Clin Immunol. 2009. PMID: 18996574
Regulatory environment for allergen-specific immunotherapy.
Kaul S, May S, Lüttkopf D, Vieths S. Kaul S, et al. Among authors: vieths s. Allergy. 2011 Jun;66(6):753-64. doi: 10.1111/j.1398-9995.2011.02552.x. Epub 2011 Feb 3. Allergy. 2011. PMID: 21288251 Review.
Foreword. Allergen products for diagnosis and therapy: regulation and science.
Rabin RL, Vieths S, Slater JE. Rabin RL, et al. Among authors: vieths s. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2013;97:1-2. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2013. PMID: 24912304 No abstract available.
Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases.
Agache I, Annesi-Maesano I, Bonertz A, Branca F, Cant A, Fras Z, Ingenrieth F, Namazova-Baranova L, Odemyr M, Spanevello A, Vieths S, Yorgancioglu A, Alvaro-Lozano M, Barber Hernandez D, Chivato T, Del Giacco S, Diamant Z, Eguiluz-Gracia I, van Wijk RG, Gevaert P, Graessel A, Hellings P, Hoffmann-Sommergruber K, Jutel M, Lau S, Lauerma A, Maria Olaguibel J, O'Mahony L, Ozdemir C, Palomares O, Pfaar O, Sastre J, Scadding G, Schmidt-Weber C, Schmid-Grendelmeier P, Shamji M, Skypala I, Spinola M, Spranger O, Torres M, Vereda A, Bonini S. Agache I, et al. Among authors: vieths s. Allergy. 2019 Nov;74(11):2064-2076. doi: 10.1111/all.13856. Epub 2019 Jun 2. Allergy. 2019. PMID: 31070805 Free article. Review.
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan-An EAACI position paper.
Klimek L, Hoffmann HJ, Kalpaklioglu AF, Demoly P, Agache I, Popov TA, Muraro A, Schmid-Grendelmeier P, Bonini S, Bonertz A, Mahler V, Vieths S, Pfaar O, Zuberbier T, Jutel M, Schmidt-Weber C, Hellings PW, Dreborg S, Bonini M, Brough HA, Bousquet J, Hoffmann-Sommergruber K, Palomares O, Ollert M, Shamji MH, Cardona V. Klimek L, et al. Among authors: vieths s. Allergy. 2020 Sep;75(9):2161-2169. doi: 10.1111/all.14329. Allergy. 2020. PMID: 32306414
Placebo effects in allergen immunotherapy-An EAACI Task Force Position Paper.
Pfaar O, Agache I, Bergmann KC, Bindslev-Jensen C, Bousquet J, Creticos PS, Devillier P, Durham SR, Hellings P, Kaul S, Kleine-Tebbe J, Klimek L, Jacobsen L, Jutel M, Muraro A, Papadopoulos NG, Rief W, Scadding GK, Schedlowski M, Shamji MH, Sturm G, van Ree R, Vidal C, Vieths S, Wedi B, Gerth van Wijk R, Frew AJ. Pfaar O, et al. Among authors: vieths s. Allergy. 2021 Mar;76(3):629-647. doi: 10.1111/all.14331. Allergy. 2021. PMID: 32324902
361 results